缺血性下肢截肢患者的当代治疗与结局:聚焦性别差异
该研究基于德国最大健康保险数据库(AOK)2010至2018年间因缺血性下肢截肢住院的39796例倾向评分匹配患者数据,分析心血管合并症、治疗及后续心血管与肢体事件,重点关注性别差异。结果显示女性他汀类(37.0% vs 42.6%)和抗血栓药物(54.9% vs 61.8%)使用率低于男性(p < .001),随访两年内女性全因死亡风险高于男性(HR 1.04,95% CI 1.04 - 1.04)。作者认为指南推荐治疗的持续缺失,尤其在女性中,可能与持续的不良结局相关,需紧急进一步研究。
要点
- 缺血性下肢截肢患者两年内全因死亡率超过50%。
- 女性他汀类(37.0% vs 42.6%)和抗血栓药物(54.9% vs 61.8%)使用率低于男性(p < .001)。
- 校正心血管合并症和血管手术后,女性死亡概率更高(HR 1.04,95% CI 1.04 - 1.04)。
核心结论
- 接受缺血性下肢截肢的患者预后仍然较差,以高复发心血管和肢体事件为特征,两年内死亡率超过50%。
- 指南推荐治疗的持续缺失,尤其在女性中,可能与持续的不良结局相关,需紧急进一步研究。
研究设计与样本
- 多部门横断面和纵向分析,使用德国最大健康保险数据库(AOK)的健康索赔数据。
- 纳入2010至2018年间因缺血性下肢截肢住院的39796例倾向评分匹配患者,匹配确保两组(男女两性中)大截肢率和年龄分布相等。
- 观察期包括指数截肢前两年及截至2019年的随访期。
主要发现
- 指数截肢前,68%的患者接受过任何类型的外周血运重建。
- 他汀类使用率女性37.0% vs 男性42.6%,抗血栓药物使用率女性54.9% vs 男性61.8%(p < .001)。
- 两年随访期间,女性与男性的肢体再截肢率为26.7% vs 31.2%,心肌梗死为10.9% vs 14.5%,卒中为20.8% vs 20.7%,全因死亡为51.0% vs 53.3%(除卒中外p < .001)。
- 校正心血管合并症和血管手术后,女性性别与更高的死亡概率相关(HR 1.04,95% CI 1.04 - 1.04)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Chronic limb threatening ischaemia (CLTI) has a devastating prognosis with high rates of lower limb amputation (LLA) and deaths. This is an illustration of contemporary management and the long term fate of patients after ischaemic LLA, particularly with respect to sex, using real world data. METHODS: This was a multisectoral cross sectional and longitudinal analysis of health claims data from the largest German health insurance database (AOK). Data of 39 796 propensity score matched patients hospitalised for ischaemic LLA between 2010 and 2018 were analysed for cardiovascular comorbidities, treatment, and for subsequent cardiovascular and limb events, with a distinct focus on sex. Matching was performed, to ensure that the rate of major amputations and the age distribution were equal in both groups (in both sexes). An observation period of two years before index and a follow up (FU) period until 2019 were included. RESULTS: Before index amputation, 68% of patients had received any kind of peripheral revascularisation. The use of statins (37.0% vs. 42.6%) and antithrombotic substances (54.9% vs. 61.8%) was lower in women than in men (p < .001). During two year FU, cardiovascular and limb events occurred among women and men as follows: limb re-amputation (26.7% vs. 31.2%), myocardial infarction (10.9% vs. 14.5%), stroke (20.8% vs. 20.7%), and death from any cause (51.0% vs. 53.3%, p < .001 except for stroke). After adjustment for cardiovascular comorbidities and vascular procedures, female sex was associated with a higher probability of death (HR 1.04, 95% CI 1.04 - 1.04). CONCLUSION: Patients undergoing ischaemic LLA still have a poor prognosis marked by high rates of recurrent cardiovascular and limb events resulting in a > 50% mortality rate within two years. The continuous lack of guideline recommended therapies, particularly in women, may be associated with the persisting poor outcome, necessitating urgent further investigation.
引用
- Makowski L, Engelbertz C, Köppe J, et al. Contemporary Treatment and Outcome of Patients with Ischaemic Lower Limb Amputation: A Focus on Sex Differences. Eur J Vasc Endovasc Surg. 2023. PMID: 37355161. doi:10.1016/j.ejvs.2023.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。